Przestrzennie rozdzielone, zintegrowane profilowaniu wieloomowe z pojedynczymi komórkami transkryptomu i epigenomicznych celów w zamrożonych sekcjach tkankowych
June 12th, 2026
112 views
To badanie przedstawia przestrzenny protokół Trekker–CUT&Tag multiome, łączący bezpośrednie przestrzenne kodowanie sekcji tkanki z analizą wielodostępu pojedynczych komórek. To podejście umożliwia przestrzennie rozdzielone profilowanie pojedynczych komórek ekspresji genów i modyfikacji histonu H3K27ac jednocześnie, oferując mechanizmy wglądu w regulację genów w kontekście mikroanatomii tkanki.
Overview
This article presents a spatial multiomic workflow that integrates spatial barcoding with single-cell profiling to analyze the molecular and cellular architecture of complex tissues. The approach enables simultaneous profiling of histone H3K27ac modifications and gene expression within single frozen brain sections, providing spatially resolved epigenomic and transcriptomic data from the same nuclei. This method enhances cell-type identification and uncovers spatially organized regulatory programs and cell-cell interactions in intact tissues.
Key Study Components
Area of Science
- Spatial multiomics
- Epigenomics
- Transcriptomics
- Neuroscience
Background
- Understanding the spatial organization of molecular features in tissues is crucial for elucidating cellular function and tissue architecture.
- Traditional single-cell assays often lack spatial context.
- Spatial barcoding technologies allow mapping of molecular data to anatomical coordinates.
- Combining epigenomic and transcriptomic profiling in a spatially resolved manner can improve cell-type annotation and reveal regulatory mechanisms.
Purpose of Study
- To develop a workflow that combines spatial barcoding with single-cell multiomic assays.
- To simultaneously profile histone modifications and gene expression in individual nuclei from frozen tissue sections.
- To generate spatially annotated multiomic data for improved tissue analysis.
Methods Used
- Embedding tissue blocks in optimal cutting temperature (OCT) freezing medium and preparing cryosections.
- Spatial barcoding of nuclei within individual tissue sections.
- Isolation of single nuclei and application of spatial CUT&Tag for H3K27ac profiling.
- Combined capture of tagmented DNAs, RNAs, and spatial barcodes, followed by library preparation and sequencing.
Main Results
- Successful generation of spatially annotated epigenomic and transcriptomic profiles from the same nuclei.
- Assignment of multiomic information to precise anatomical coordinates within tissue sections.
- Improved fidelity in cell-type identification through integration of epigenomic and transcriptomic data.
- Revelation of spatially organized regulatory programs and cell-cell interactions in brain tissue.
Conclusions
- The spatial CUT&Tag multiome workflow enables comprehensive spatially resolved molecular analysis of complex tissues.
- Integrating epigenomic and transcriptomic data enhances cell-type annotation and understanding of tissue organization.
- This approach provides new insights into spatial regulatory mechanisms and cellular interactions within intact tissues.
Frequently Asked Questions
What is the main innovation of this spatial multiome workflow?
The workflow enables simultaneous spatial profiling of histone modifications and gene expression in single nuclei from frozen tissue sections, providing integrated multiomic data with anatomical context.
How does spatial barcoding contribute to the analysis?
Spatial barcoding assigns molecular data from each nucleus to specific anatomical coordinates, allowing researchers to map molecular features within the tissue architecture.
What types of molecular information are obtained from this method?
The method provides both epigenomic (histone H3K27ac modifications) and transcriptomic (gene expression) profiles from the same nuclei.
Why is integrating epigenomic and transcriptomic data important?
Integration improves the accuracy of cell-type identification and reveals spatially organized regulatory programs and cell-cell interactions that are not apparent from single-omic data alone.
What tissues can be analyzed using this workflow?
While demonstrated on frozen brain sections, the workflow can be adapted to other tissue types embedded in OCT and prepared as cryosections.
What are the potential applications of this technology?
Applications include mapping cellular heterogeneity, studying tissue organization, and investigating spatial regulatory mechanisms in health and disease.
Executive Industry Relevance
Spatially resolved single-cell multiomic profiling enables biopharma teams to dissect the molecular architecture of complex tissues with unprecedented precision. Integrating spatial barcoding with simultaneous transcriptomic and epigenomic analysis enhances predictive confidence in cell-type identification and regulatory pathway mapping. This capability supports critical inflection points in target validation and translational research by revealing spatially organized regulatory programs and cell-cell interactions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables high-resolution mapping of regulatory elements and gene expression within anatomical context.
- Supports functional target validation by linking epigenomic states to spatially defined cell populations.
- Facilitates mechanistic de-risking through integrated multiomic data from the same nuclei.
- Improves predictive confidence for prioritizing targets based on spatial regulatory programs.
Screening & Assay Development
- Provides validated spatially annotated biological systems for downstream screening workflows.
- Enables assay standardization by integrating spatial and molecular barcoding in frozen tissue sections.
- Delivers reproducible, quantitative multiomic outputs for robust compound evaluation.
- Supports platform scalability and reuse across diverse tissue types and disease models.
Translational & Preclinical Research
- Aligns molecular profiling with disease-relevant anatomical coordinates for translational biomarker discovery.
- Ensures continuity from discovery through preclinical validation by integrating spatial and molecular data.
- Enables risk-adjusted advancement decisions based on spatially resolved regulatory mechanisms.
- Reveals cell-cell interactions and tissue organization critical for preclinical model selection.
Pipeline & Workflow Integration
This spatial multiomic workflow bridges early discovery, lead identification, and translational research by providing integrated, spatially resolved molecular data from frozen tissue sections.
- Discovery Biology: Supports hypothesis testing and pathway clarification by mapping regulatory modifications and gene expression to anatomical structures.
- Screening: Delivers assay-ready, spatially annotated nuclei for reproducible and quantitative downstream analysis.
- Analytics: Generates high-content multiomic readouts enabling direct comparison of spatially distinct cell populations.
- Translational Research: Facilitates biomarker alignment and disease model validation through spatially organized molecular insights.
- Enterprise Reuse: Establishes a reusable workflow adaptable to multiple tissue types and research programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Standardizes spatial multiomic profiling for reproducibility and scalability across projects.
- Strategic Value: Enables informed go/no-go decisions and capital-efficient portfolio management.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of high-confidence targets.
Implementation Considerations
- Requires expertise in spatial barcoding, single-cell multiomics, and sequencing technologies.
- Demands access to cryosectioning, spatial barcoding reagents, and high-throughput sequencing infrastructure.
- Necessitates cross-team standardization of sample preparation and data integration workflows.
- Adaptable to various tissue types embedded in OCT and prepared as cryosections.
- Dependent on robust analytical pipelines for spatially resolved multiomic data interpretation.
Biopharma FAQs
Why does null hypothesis testing matter for spatial multiomic target validation?
Null hypothesis testing enables teams to rigorously assess whether observed spatial differences in gene expression or epigenomic marks are statistically significant, supporting confident target validation within anatomically defined regions.
How does independent variable isolation fit spatial barcoding in discovery?
Isolating spatially barcoded nuclei allows researchers to attribute molecular changes to specific anatomical locations, clarifying the impact of spatial context as an independent variable in discovery-stage analyses.
What do quantitative dependent variable measurements enable in spatial CUT&Tag?
Quantitative measurement of histone modifications and gene expression from the same nuclei enables direct comparison of molecular states across spatial coordinates, informing mechanistic insights and target prioritization.
Why are replication requirements critical for cross-functional spatial multiomic studies?
Replication across tissue sections and experiments ensures that spatially resolved multiomic findings are robust and reproducible, facilitating collaboration and data integration across discovery and translational teams.
What statistical analysis capabilities are required before spatial multiomic implementation?
Robust statistical tools are needed to analyze spatially resolved multiomic data, including methods for differential expression, spatial clustering, and integration of epigenomic and transcriptomic profiles to support actionable R&D decisions.